Gatto, Laurent http://orcid.org/0000-0002-1520-2268
Aebersold, Ruedi http://orcid.org/0000-0002-9576-3267
Cox, Juergen http://orcid.org/0000-0001-8597-205X
Demichev, Vadim http://orcid.org/0000-0002-2424-9412
Derks, Jason http://orcid.org/0000-0001-9727-9105
Emmott, Edward http://orcid.org/0000-0002-3239-8178
Franks, Alexander M.
Ivanov, Alexander R.
Kelly, Ryan T.
Khoury, Luke http://orcid.org/0000-0001-7794-6812
Leduc, Andrew
MacCoss, Michael J. http://orcid.org/0000-0003-1853-0256
Nemes, Peter http://orcid.org/0000-0002-4704-4997
Perlman, David H.
Petelski, Aleksandra A.
Rose, Christopher M. http://orcid.org/0000-0002-7502-3368
Schoof, Erwin M. http://orcid.org/0000-0002-3117-7832
Van Eyk, Jennifer http://orcid.org/0000-0001-9050-148X
Vanderaa, Christophe http://orcid.org/0000-0001-7443-5427
Yates, John R. III http://orcid.org/0000-0001-5267-1672
Slavov, Nikolai http://orcid.org/0000-0003-2035-1820
Funding for this research was provided by:
Paul G. Allen Family Foundation (Allen Distinguished Investigator award)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (1UG3CA268117)
Article History
Received: 6 June 2022
Accepted: 24 January 2023
First Online: 2 March 2023
Competing interests
: R.T.K. has a financial interest in MicrOmics Technologies. C.M.R. is an employee Genentech and a shareholder in Roche.